Stay updated on Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical study on Nintedanib for COVID-19 and the addition of a new revision number. The name 'Huilanz Zhang' has been added, which may indicate a relevant individual associated with the content.SummaryDifference22%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.